Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Development and Application of "Scar-care" Padding on Management of Hypertrophic Scar

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03469830
Recruitment Status : Completed
First Posted : March 19, 2018
Last Update Posted : March 29, 2018
Sponsor:
Information provided by (Responsible Party):
The Hong Kong Polytechnic University

Brief Summary:
This study explores the smart scar care pad's potential therapeutic effect in treatment hypertrophic scar while elucidating the adverse effects if there is any. Half of the participant receives traditional treatment of pressure garment and the other half receives the smart scar care pad together with pressure garment.

Condition or disease Intervention/treatment Phase
Cicatrix, Hypertrophic Rehabilitation Other: SSCP Other: SPMS Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 8 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Masking Description: The subjects and the analyser of the data were blinded.
Primary Purpose: Treatment
Official Title: The Effectiveness of a Smart Scar Care Pad and Pressure Therapy Versus Pressure Therapy in Hypertrophic Scar Management: a Pilot Study
Actual Study Start Date : November 1, 2015
Actual Primary Completion Date : November 1, 2016
Actual Study Completion Date : November 1, 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Scars

Arm Intervention/treatment
Experimental: SSCP & SPMS

The smart scar care pad (SCCP):

The SCCP is a newly invented insert material that can maximise treatment outcomes via enhanced compression and occlusion. The wearing regime for SCCP is 4 hours a day for the first day, with 2-hour increments added every other day until the total wearing time reached 23 hours. SSCP was cleaned twice a day for hygienic reasons.

The smart pressure monitored suit(SPMS):

The SPMS is a type of custom-made pressure garment. SPMS was used 23 hours a day and only removed when showering.

Other: SSCP
Insert
Other Name: The Smart Scar Care PAd

Other: SPMS
Pressure therapy
Other Name: The Smart Pressure Monitored Suit

Active Comparator: SPMS

The smart pressure monitored suit(SPMS):

The SPMS is a type of custom-made pressure garment. SPMS was used 23 hours a day and only removed when showering.

Other: SPMS
Pressure therapy
Other Name: The Smart Pressure Monitored Suit




Primary Outcome Measures :
  1. Change of Scar Pliability measured by the DermaLab Combo [ Time Frame: baseline and 6 weeks ]
    Scar pliability is represented by the Young's modulus measured by the elasticity measurement of the DermaLab Combo


Secondary Outcome Measures :
  1. Change of Scar Thickness measured by the diagnostic ultrasound system [ Time Frame: baseline and 6 weeks ]
    Scar thickness is measured by the diagnostic ultrasound system

  2. Change of Scar Pigmentation measured by the DermaLab Combo [ Time Frame: baseline and 6 weeks ]
    Scar pigmentation is represented by the melanin score generated by the color probe of the DermaLab Combo. The range of the score is 0-100, where a higher score indicates a higher melanin content.

  3. Change of Scar Vascularity measured by the DermaLab Combo [ Time Frame: baseline and 6 weeks ]
    Scar vascularity is represented by the erythema score measured by the color probe of the DermaLab Combo. The range of the score is 0-100, where a higher score indicates a more erythematic situation.

  4. Occurrence of blistering [ Time Frame: up to 6 weeks ]
    Occurence of blistering is observed and reported by research staff

  5. Occurrence of skin breakdown [ Time Frame: up to 6 weeks ]
    Occurence of skin breakdown is observed and reported by research staff

  6. Occurrence of rash [ Time Frame: up to 6 weeks ]
    Occurence of rash is observed and reported by research staff



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Subjects with Hypertrophic Scar(HS);
  2. the HS had a total Vancouver Scar Scale (VSS) score of 4 or higher and the score of each item equal to or greater than 1;
  3. subjects age between 20 and 70 years, cooperative, and good compliance with treatment.

Exclusion Criteria:

  1. the HS area had an open wound or infection;
  2. the HS had been treated with steroid injections or other intervention (such as traditional Chinese medicine or laser therapy) before the study; or
  3. the patient had a medical condition that might affect wound healing (e.g., diabetes mellitus or another serious medical problem).
Layout table for additonal information
Responsible Party: The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier: NCT03469830    
Other Study ID Numbers: HSEARS20140618002-01
First Posted: March 19, 2018    Key Record Dates
Last Update Posted: March 29, 2018
Last Verified: March 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by The Hong Kong Polytechnic University:
insert
pressure therapy
silicone gel
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypertrophy
Cicatrix, Hypertrophic
Cicatrix
Pathological Conditions, Anatomical
Fibrosis
Pathologic Processes